This website requires Javascript for some parts to function propertly. Your experience may vary.

Hengeler Mueller advises EQT on investment in Otto Bock | Hengeler Mueller News

Hengeler Mueller advises EQT on investment in Otto Bock

 The German entrepreneur Professor Hans Georg Näder has entered into an agreement with funds advised by EQT regarding the acquisition of a 20-percent participation in Otto Bock HealthCare GmbH. Otto Bock Group, headquartered in Duderstadt, Germany, is active in the fields of prosthetic and orthotic products, human mobility and medical care and operates with approx. 7,000 employees worldwide in more than 50 countries. In 2016, Otto Bock Group generated more than EUR 880m in revenues. The closing of the transaction is subject to customary merger clearance and expected for the third quarter of 2017.

Hengeler Mueller advised EQT on the transaction. The Hengeler Mueller team was led by partners Steffen Oppenländer (M&A, London) and Hans-Jörg Ziegenhain (M&A, Munich) and included partners Viola Sailer-Coceani (Corporate, Munich), Daniela Böning (Financing), Hendrik Bockenheimer (Labour), Thomas Kraft (Tax) (all Frankfurt), Markus Röhrig (Antitrust, Brussels) and Dirk Uwer (Regulatory, Healthcare/Life Sciences, Düsseldorf), and counsel Mathias Link (Tax, Frankfurt), Andrea Schlaffge and Patrick H. Wilkening (both IP/IT, Düsseldorf) as well as associates Michael Born (Corporate/M&A, London), Stefanie Budde (Antitrust, Düsseldorf), Hermann Dahlitz (Berlin), Konrad Rotthege (London) (both Corporate/M&A), Eckbert Mueller (Labour, Frankfurt), Susanne Koch, Deniz Tschammler (both Regulatory, Healthcare/Life Sciences) and Maximilian Tim Wosgien (IP/IT) (all Düsseldorf).

Latest Articles

BRUSSELS À JOUR – Rockin‘ Around the Christmas Tree

AIFMD II update: ESMA consultation paper on open-ended loan-originating AIFs

Video: Our Restructuring Team

Recent Mergers & Acquisitions Work